ATOS

Atossa Therapeutics (ATOS)

About Atossa Therapeutics (ATOS)

Atossa Therapeutics, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions. The company was founded by Steven C. Quay and Shu Chih Chen in December 2008 and is headquartered in Seattle, WA.

Details

Daily high

$1.02

Daily low

$0.96

Price at open

$0.97

52 Week High

$2.31

52 Week Low

$0.77

Market cap

121.2M

Dividend yield

0.00%

Volume

1.1M

Avg. volume

954,067

P/E ratio

-4.49

Atossa Therapeutics News